Eptifibatide
Eptifibatide
7 Amino Acids · MW: 831.96 Da
Amino Acids
7
Molecular Weight
831.96 Da
Half-life
2.5 h
Research Score
4.7
Studies
98
Storage
Store lyophilized at -20°C, reconstituted at 2-8°C
What is Eptifibatide?
Eptifibatide is a cyclic heptapeptide antiplatelet drug derived from the barbourin motif of pygmy rattlesnake venom. It blocks the platelet glycoprotein IIb/IIIa receptor and is used to reduce thrombotic risk in acute coronary settings.
Key Benefits & Mechanisms
acute coronary syndrome support
platelet aggregation inhibition
PCI adjunct therapy
Research Summary
Originated from a rattlesnake venom motif and became an FDA-approved GP IIb/IIIa inhibitor. It is a landmark example of venom peptide optimization into a mainstream cardiovascular drug.
Related Peptides
Crotamine
Crotamine
Crotamine is a basic 42-residue peptide from South American rattlesnake venom. It is a cell-penetrating toxin studied as a probe for ion channels and as a potential tumor-targeting delivery scaffold.
Venom-DerivedEchistatin
Echistatin
Echistatin is a small RGD-containing disintegrin from saw-scaled viper venom. It binds integrins and inhibits platelet adhesion, making it a classic tool in thrombosis and cell-adhesion research.
Venom-DerivedPsalmotoxin-1
Psalmotoxin-1 (PcTx1)
Psalmotoxin-1 is a tarantula venom peptide that selectively inhibits acid-sensing ion channel 1a. It is widely used to study pain signaling, ischemia, and neurodegenerative mechanisms.
Venom-DerivedCharybdotoxin
Charybdotoxin
Charybdotoxin is a scorpion venom peptide that blocks several potassium channels, especially large-conductance calcium-activated potassium channels. It is a foundational electrophysiology tool for mapping channel function and selectivity.
Venom-Derived